The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback